Hospitalization for heart failure (HF) marks a pivotal event in the disease course of our patients, one that carries a 1-year mortality rate of 25%. Despite advances in pharmacologic and cardiac resynchronization therapies, the number of hospitalizations for HF remains high (an estimated 809,000 patients in 2016) with 30-day HF readmission rates of 20%.